Experimental therapeutics for gastric cancer using adenovirus vectors
Project/Area Number |
08671476
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | NARA MEDICAL UNIVERSITY |
Principal Investigator |
YAMADA Yukishige (1998) Nara Medical University, First Departmentof Surgery, Research Associate, 医学部, 助手 (50254496)
渡辺 明彦 (1996-1997) 奈良県立医科大学, 医学部, 講師 (80211671)
|
Co-Investigator(Kenkyū-buntansha) |
SAWADA Hidetomo Nara Medical University, First Departmentof Surgery, Assistant professor, 医学部, 講師 (10206021)
山田 行重 奈良県立医科大学, 医学部, 助手 (50254496)
|
Project Period (FY) |
1996 – 1998
|
Project Status |
Completed (Fiscal Year 1998)
|
Budget Amount *help |
¥2,600,000 (Direct Cost: ¥2,600,000)
Fiscal Year 1998: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1997: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 1996: ¥700,000 (Direct Cost: ¥700,000)
|
Keywords | Gastric Cancer / Adenovirus Vector / アデノウィルスベクター / アデノウィルス |
Research Abstract |
1) EGER and c-met expression after EGFR and c-met antisense expressing adenovirus in gastric cancer cells Following infection with EGFR or c-met antisense RNA-expressing adenovirus(Ad-EAS or Ad-MAS), the cell surface EGER or c-met protein levels of infected cancer cell were observed by immunocytological method resulting in that markedly reduction of these proteins respectively. These suppression was not observed in non-infection or beta-galactosidase expressing adenovirus(Ad-GAL) infected group. 2) The effect of Ad-EAS virus on the growth of gastric cancer cells in vitro and in vivo. Following infection with EGFR antisense RNA-expressing adenovirus(Ad-EAS), the in vitro growth of Ad-EAS infected cells was significantly inhibited relative to control infected cells in 3 gastric cancer cell lines (AGS, KKLS, MKN28) studied here(p(]SY.di-substituted right.[)O.0002). In a nude mouse subcutaneous tumor system, in vivo tumor growth of MKN28 was significantly inhibited after Ad-EAS treatment, and the inhibition on the 48th day was 93% by volume compared to that of untreated controls. 3) The effect of Ad-MAS virus on cancer cell motility in gastric cancer cells. After Ad-MAS virus infection, the cell motility of AGS (c-met expressing) and Hs746t (c-met overexpressing) were significantly inhibited in comparison with control groups. The inhibition rate compare to non-infection group were 88% in AGS and 45% in Hs746t, respectively. These motility inhibition was not observed in KKLS cell (c-met non-expressing).
|
Report
(4 results)
Research Products
(4 results)